Showing results (41-50 of 56) with videos related to
Sort By:
Pageof 6
Vaccine|November 10, 2015
Absence of venous thromboembolism risk following quadrivalent human papillomavirus vaccination, Vaccine Safety Datalink, 2008-2011Allison L Naleway, Brad Crane, Ning Smith, et al.Influenza and Other Respiratory Viruses|June 13, 2012
Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000-2010Sharon K Greene, David K Shay, Ruihua Yin, et al.Vaccine|December 27, 2012
Secular trends in diagnostic code density in electronic healthcare data from health care systems in the Vaccine Safety Datalink projectRulin C Hechter, Lei Qian, Lina S Sy, et al.Pharmacoepidemiology and Drug Safety|November 7, 2012
Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007-2010Sharon K Greene, Lingling Li, David K Shay, et al.American Journal of Epidemiology|January 8, 2013
Adapting group sequential methods to observational postlicensure vaccine safety surveillance: results of a pentavalent combination DTaP-IPV-Hib vaccine safety studyJennifer C Nelson, Onchee Yu, Clara P Dominguez-Islas, et al.American Journal of Epidemiology|December 8, 2009
Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink ProjectSharon K Greene, Martin Kulldorff, Edwin M Lewis, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 18, 2021
Population-Based Estimates of Coronavirus Disease 2019 (COVID-19)-like Illness, COVID-19 Illness, and Rates of Case Ascertainment, Hospitalizations, and Deaths-Noninstitutionalized New York City Residents, March-April 2020Karen A Alroy, Aldo Crossa, Christine Dominianni, et al.Vaccine|November 10, 2015
Evaluation of the risk of venous thromboembolism after quadrivalent human papillomavirus vaccination among US femalesW Katherine Yih, Sharon K Greene, Lauren Zichittella, et al.BMC Public Health|December 12, 2019
Applying infectious disease forecasting to public health: a path forward using influenza forecasting examplesChelsea S Lutz, Mimi P Huynh, Monica Schroeder, et al.The Journal of Infectious Diseases|January 10, 2023
Pfizer-BioNTech Coronavirus Disease 2019 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Long-term Care Facility Staff With and Without Prior Infection in New York City, January-June 2021Kathryn Peebles, Robert J Arciuolo, Anthony S Romano, et al.Pageof 6